Attention and the cholinergic system: Relevance to schizophrenia

Current Topics in Behavioral Neurosciences

Volumn 28, Issue , 2016, Pages 327-362

  Lustig, Cindy ^a   Sarter, Martin ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acetylcholine; Attentional effort; Cross species; Right prefrontal cortex; Schizophrenia

Indexed keywords

ACETYLCHOLINE; MUSCARINIC RECEPTOR;

ATTENTION; BRAIN DYSFUNCTION; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; DOPAMINERGIC TRANSMISSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GABAERGIC TRANSMISSION; GENETIC POLYMORPHISM; HUMAN; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; ANIMAL; BRAIN; CHOLINERGIC NERVE CELL; COGNITION; METABOLISM; NERVE TRACT; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ATTENTION; BRAIN; CHOLINERGIC NEURONS; COGNITION; HUMANS; NEURAL PATHWAYS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84988651783     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2015_5009     Document Type: Chapter

References (192)

1. Akitsuki Y, Sugiura M, Watanabe J, Yamashita K, Sassa Y, Awata S, Kawashima R (2003) Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI study. Neuroimage 19(4): 1674-1685. doi: 10.1016/s1053-8119(03)00250-7
2. Alexander MP, Stuss DT, Shallice T, Picton TW, Gillingham S (2005) Impaired concentration due to frontal lobe damage from two distinct lesion sites. Neurology 65(4): 572-579. doi: 10.1212/01.wnl.0000172912.07640.92
3. Apostol G, Abi-Saab W, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Saltarelli MD (2012) Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology 219(3): 715-725. doi: 10.1007/s00213-011-2393-2
4. Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M (2005) Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J Neurosci 25(15): 3851-3856. doi: 10.1523/jinneurosci.0505.-05.2005
5. Bain EE, Robieson W, Pritchett Y, Garimella T, Abi-Saab W, Apostol G, Saltarelli MD (2013) A randomized, double-blind, placebo-controlled phase 2 study of alpha 4 beta 2 agonist ABT-894 in adults with ADHD. Neuropsychopharmacology 38(3): 405-413. doi: 10.1038/npp.2012.194
6. Barch DM, Dowd EC (2010) Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull 36(5): 919-934. doi: 10.1093/schbul/sbq068
7. Bauer M, Kluge C, Bach D, Bradbury D, Heinze HJ, Dolan RJ, Driver J (2012) Cholinergic enhancement of visual attention and neural oscillations in the human brain. Curr Biol 22 (5): 397-402. doi: 10.1016/j.cub.2012.01.022
8. Belujon P, Grace AA (2008) Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J Neurosci 28: 9797-9805
9. Bentley P, Driver J, Dolan RJ (2011) Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Prog Neurobiol 94(4): 360-388. doi: 10.1016/j.pneurobio.2011.06.002
10. Berry AS, Demeter E, Sabhapathy S, English BA, Blakely RD, Sarter M, Lustig C (2014) Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. J Cogn Neurosci 26(9): 1981-1991. doi: 10.1162/jocn_a_00607
11. Berry AS, Blakely RD, Sarter M, Lustig C (2015) Cholinergic capacity mediates prefrontal engagement during challenges to attention: evidence from imaging genetics. Neuroimage 108: 386-395. doi: 10.1016/j.neuroimage.2014.12.036
12. Berry AS, Sarter M, Lustig C (in prep) Frontoparietal correlates of attentional effort during challenges to attention
13. Berry AS, Sarter M, Gehring WJ, Lustig C (in prep) Going in: frontoparietal responses associated with shifts from perceptual to reflective attention
14. Blatow M, Rozov A, Katona I, Hormuzdi SG, Meyer AH, Whittington MA, Monyer H (2003) A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 38(5): 805-817. doi: 10.1016/s0896-6273(03)00300-3
15. Bloem B, Poorthuis RB, Mansvelder HD (2014a) Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity. Frontiers Neural Circ 8. doi: 10.3389/fncir.2014.00017
16. Bloem B, Schoppink L, Rotaru DC, Faiz A, Hendriks P, Mansvelder HD, van de Berg WD, Wouterlood FG (2014b) Topographic mapping between basal forebrain cholinergic neurons and the medial prefrontal cortex in mice. J Neurosci 34: 16234-16246
17. Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD (2008) Predicting schizophrenia patients’ real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry 63(5): 505-511. doi: 10.1016/j.biopsych.2007.05.022
18. Brady AM, O’Donnell P (2004) Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 24: 1040-1049
19. Braver TS (2012) The variable nature of cognitive control: a dual mechanisms framework. Trends Cogn Sci 16(2): 106-113. doi: 10.1016/j.tics.2011.12.010
20. Briand LA, Gritton H, Howe WM, Young DA, Sarter M (2007) Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol 83(2): 69-91. doi: 10.1016/j.pneurobio.2007.06.007
21. Burgess PW, Dumontheil I, Gilbert SJ (2007) The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends Cogn Sci 11(7): 290-298. doi: 10.1016/j.tics.2007.05.004
22. Cader S, Cifelli A, Abu-Omar Y, Palace J, Matthews PM (2006) Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain 129: 527-537. doi: 10.1093/brain/awh670
23. Cairo TA, Woodward TS, Ngan ETC (2004) An event-related fMRI study of maintenance brain activity in schizophrenia during the performance of a variable load working memory task. Schizophr Res 67(1): 262
24. Callaway E III, Jones RT, Donchin E (1970) Auditory evoked potential variability in schizophrenia. Electroencephalogr Clin Neurophysiol 29(5): 421-428
25. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9(1): 20-26. doi: 10.1093/cercor/9.1.20
26. Cappell KA, Gmeindl L, Reuter-Lorenz PA (2010) Age differences in prefontal recruitment during verbal working memory maintenance depend on memory load. Cortex 46(4): 462-473. doi: 10.1016/j.cortex.2009.11.009
27. Carr DB, Sesack SR (2000) Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 20: 3864-3873
28. Castellanos FX, Sonuga-Barke EJS, Scheres A, Di Martino A, Hyde C, Walters JR (2005) Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiatry 57(11): 1416-1423. doi: 10.1016/j.biopsych.2004.12.005
29. Castro-Alamancos MA, Gulati T (2014) Neuromodulators produce distinct activated states in neocortex. J Neurosci 34: 12353-12367
30. Chun MM, Johnson MK (2011) Memory: enduring traces of perceptual and reflective attention. Neuron 72(4): 520-535. doi: 10.1016/j.neuron.2011.10.026
31. Cole VT, Weinberger DR, Dickinson D (2011) Intra-individual variability across neuropsychological tasks in schizophrenia: a comparison of patients, their siblings, and healthy controls. Schizophr Res 129(1): 91-93. doi: 10.1016/j.schres.2011.03.007
32. Cornblatt BA, Keilp JG (1994) Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20(1): 31-46
33. Dani JA, Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699-729
34. Deco G, Thiele A (2011) Cholinergic control of cortical network interactions enables feedback-mediated attentional modulation. Eur J Neurosci 34(1): 146-157. doi: 10.1111/j.1460-9568.2011.07749.x
35. Demeter E, Sarter M, Lustig C (2008) Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 22(6): 787-799. doi: 10.1037/a0013712
36. Demeter E, Hernandez-Garcia L, Sarter M, Lustig C (2011) Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage 54(2): 1518-1529. doi: 10.1016/j.neuroimage.2010.09.026
37. Demeter E, Guthrie SK, Taylor SF, Sarter M, Lustig C (2013) Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational sustained attention task. Schizophr Res 144(1-3): 136-141. doi: 10.1016/j.schres.2013.01.003
38. Demeter E, de Alburquerque D, Woldorff M (2015) The effects of distraction on the brain processes underlying signal detection. Poster presented at the Cognitive Neuroscience Society Meeting, New York
39. Deserno L, Boehme R, Heinz A, Schlagenhauf F (2013) Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Frontiers Psychiatry 4: 172. doi: 10.3389/fpsyt.2013.00172
40. Dima D, Dietrich DE, Dillo W, Emrich HM (2010) Impaired top-down processes in schizophrenia: a DCM study of ERPs. Neuroimage 52(3): 824-832. doi: 10.1016/j.neuroimage.2009.12.086
41. Disney AA, Aoki C (2008) Muscarinic acetylcholine receptors in macaque v1 are most frequently expressed by parvalbumin-immunoreactive neurons. J Comp Neurol 507(5): 1748-1762. doi: 10.1002/cne.21616
42. Donchin E, Callaway E, Jones RT (1970) Auditory evoked potential variability in schizophrenia.2. Application of discriminant analysis. Electroencephalogr Clin Neurophysiol 29(5): 429. doi: 10.1016/0013-4694(70)90060-x
43. Egeland J, Rund BR, Sundet K, Landro NI, Asbjornsen A, Lund A, Hugdahl K (2003) Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatr Scand 108(4): 276-284. doi: 10.1034/j.1600-0447.2003.00146.x
44. Flagel SB, Akil H, Robinson TE (2009) Individual differences in the attribution of incentive salience to reward-related cues: implications for addiction. Neuropharmacology 56: 139-148. doi: 10.1016/j.neuropharm.2008.06.027
45. Flagel SB, Clark JJ, Robinson TE, Mayo L, Czuj A, Willuhn I, Akil H (2011) A selective role for dopamine in stimulus-reward learning. Nature 469(7328): 53-63. doi: 10.1038/nature09588
46. Fletcher PC, McKenna PJ, Frith CD, Grasby PM, Friston KJ, Dolan RJ (1998) Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch Gen Psychiatry 55: 1001-1008. doi: 10.1001/archpsyc.55.11.1001
47. Floresco SB (2015) The nucleus accumbens: an interface between cognition, emotion, and action. Annu Rev Psychol 66(66): 25-52. doi: 10.1146/annurev-psych-010213-115159
48. Ford JM, White P, Lim KO, Pfefferbaum A (1994) Schizophrenics have fewer and smaller p300s -a single-trial analysis. Biol Psychiatry 35(2): 96-103. doi: 10.1016/0006-3223(94)91198-3
49. Foster DJ, Choi DL, Conn PJ, Rook JM (2014) Activation of M-1 and M-4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia. Neuropsychiatr Dis Treat 10: 183-191. doi: 10.2147/ndt.s55104
50. Fukushima J, Morita N, Fukushima K, Chiba T, Tanaka S, Yamashita I (1990) Voluntary control of saccadic eye-movements in patients with schizophrenic and affective-disorders. J Psychiatr Res 24(1): 9. doi: 10.1016/0022-3956(90)90021-h
51. Gagne A-M, Hebert M, Maziade M (2015) Revisiting visual dysfunctions in schizophrenia from the retina to the cortical cells: a manifestation of defective neurodevelopment. Prog Neuropsychopharmacol Biol Psychiatry 62: 29-34. doi: 10.1016/j.pnpbp.2015.04.007
52. Gaykema RP, van Weeghel R, Hersh LB, Luiten PG (1991) Prefrontal cortical projections to the cholinergic neurons in the basal forebrain. J Comp Neurol 303: 563-583
53. Giesbrecht B, Woldorff MG, Song AW, Mangun GR (2003) Neural mechanisms of top-down control during spatial and feature attention. Neuroimage 19(3): 496-512. doi: 10.1016/s1053-8119(03)00162-9
54. Gilmour G, Gastambide F, Marston H, Walton ME (2015) Using intermediate cogntiive endpoints to facilitate translational research in schizophrenia. Curr Opin Behav Sci 4: 128-135
55. Goghari VM (2011) Executive functioning-related brain abnormalities associated with the genetic liability for schizophrenia: an activation likelihood estimation meta-analysis. Psychol Med 41 (6): 1239-1252. doi: 10.1017/s0033291710001972
56. Gold JM, Fuller RL, Robinson BM, Braun EL, Luck SJ (2007) Impaired top-down control of visual search in schizophrenia. Schizophr Res 94(1-3): 148-155. doi: 10.1016/j.schres.2007.04.023
57. Gorka AX, Hanson JL, Radtke SR, Hariri AR (2014) Reduced hippocampal and medial prefrontal gray matter mediate the association between reported childhood maltreatment and trait anxiety in adulthood and predict sensitivity to future life stress. Biol Mood Anxiety Disord 4: 12. doi: 10.1186/2045-5380-4-12
58. Gracitelli CPB, Abe RY, Diniz-Filho A, Vaz-de-Lima FB, Paranhos A Jr, Medeiros FA (2015) Ophthalmology issues in schizophrenia. Curr Psychiatr Rep 17(5). doi: 10.1007/s11920-015-0569-x
59. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153(3): 321-330
60. Grillon C, Courchesne E, Ameli R, Geyer MA, Braff DL (1990) Increased distractibility in schizophrenic-patients-electrophysiologic and behavioral evidence. Arch Gen Psychiatry 47 (2): 171-179
61. Hahn B, Robinson BM, Kaiser ST, Matveeva TM, Harvey AN, Luck SJ, Gold JM (2012) Kraepelin and bleuler had it right: people with schizophrenia have deficits sustaining attention over time. J Abnorm Psychol 121(3): 641-648. doi: 10.1037/a0028492
62. Hangya B, Ranade SP, Lorenc M, Kepecs A (2015) Central cholinergic neurons are rapidly recruited by reinforcement feedback. Cell 162(5): 1155-1168. doi: 10.1016/j.cell.2015.07.057
63. Hasselmo ME, McGaughy J (2004) High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. In: Descarries L, Krnjevic K, Steriade M (eds) Acetylcholine in the cerebral cortex 145: 207-231
64. Hasselmo ME, Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36(1): 52-73. doi: 10.1038/npp.2010.104
65. Hasselmo ME, Anderson BP, Bower JM (1992) Cholinergic modulation of cortical associative memory function. J Neurophysiol 67(5): 1230-1246
66. Higley MJ, Picciotto MR (2014) Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol 29C: 88-95
67. Himmelheber AM, Sarter M, Bruno JP (2000) Increases in cortical acetylcholine release during sustained attention performance in rats. Brain Res Cogn Brain Res 9(3): 313-325
68. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35: 549-562
69. Howe WM, Ji J, Parikh V, Williams S, Mocaer E, Trocme-Thibierge C, Sarter M (2010) Enhancement of attentional performance by selective stimulation of alpha 4 beta 2*nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 35(6): 1391-1401. doi: 10.1038/npp.2010.9
70. Howe WM, Berry AS, Francois J, Gilmour G, Carp JM, Tricklebank M, Sarter M (2013) Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans. J Neurosci 33(20): 8742-8752. doi: 10.1523/jneurosci.5809-12.2013
71. Jablensky A (2015) Schizophrenia or schizophrenias? The challenge of genetic parsing of a complex disorder. Am J Psychiatr 172(2): 105-107. doi: 10.1176/appi.ajp.2014.14111452
72. Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajos M (2008) Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 7(1): 68-83. doi: 10.1038/nrd2463
73. Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Kapur S (2008) The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33(3): 473-479. doi: 10.1038/sj.npp.1301437
74. Ji W, Gămănuţ R, Bista P, D’Souza RD, Wang Q, Burkhalter A (2015) Modularity in the organization of mouse primary visual cortex. Neuron 87: 632-643
75. Jimura K, Locke HS, Braver TS (2010) Prefrontal cortex mediation of cognitive enhancement in rewarding motivational contexts. Proc Nat Acad Sci USA 107(19): 8871-8876. doi: 10.1073/pnas.1002007107
76. Kaiser S, Roth A, Rentrop M, Friederich H-C, Bender S, Weisbrod M (2008) Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain Cogn 66(1): 73-82. doi: 10.1016/j.bandc.2007.05.007
77. Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27: 1081-1090
78. Keefe RSE, Vinogradov S, Medalia A, Silverstein SM, Bell MD, Dickinson D, Stroup TS (2011) Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull 37(5): 1057-1065. doi: 10.1093/schbul/sbq010
79. Koch K, Wagner G, Schultz C, Schachtzabel C, Nenadic I, Axer M, Schloesser RGM (2009) Altered error-related activity in patients with schizophrenia. Neuropsychologia 47(13): 2843-2849. doi: 10.1016/j.neuropsychologia.2009.06.010
80. Koch K, Schachtzabel C, Wagner G, Schikora J, Schultz C, Reichenbach JR, Sauer H, Schlosser RGM (2010) Altered activation in association with reward-related trial-and-error activity in patients with schizophrenia. NeuroImage 50: 223-232
81. Kogoj A, Pirtosek Z, Tomori M, Vodusek DB (2005) Event-related potentials elicited by distractors in an auditory oddball paradigm in schizophrenia. Psychiatry Res 137(1-2): 49-59. doi: 10.1016/j.psychres.2005.07.017
82. Kozak R, Bruno JP, Sarter M (2006) Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex 16(1): 9-17. doi: 10.1093/cercor/bhi079
83. Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M (2007) Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 32(10): 2074-2086. doi: 10.1038/sj.npp.1301352
84. Krebs M, Boehler N, Roberts C, Song W, Woldorff G (2012) The involvement of the dopaminergic midbrain and cortico-striatal-thalamic circuits in the integration of reward prospect and attentional task demands. Cereb Cortex 22: 607-615
85. Kruse AC, Weiss DR, Rossi M, Hu J, Hu K, Eitel K, Shoichet BK (2013) Muscarinic receptors as model targets and antitargets for structure-based ligand discovery. Mol Pharmacol 84(4): 528-540. doi: 10.1124/mol.113.087551
86. Kucinski A, Sarter M (2015) Modeling parkinson’s disease falls associated with brainstem cholinergic systems decline. Behav Neurosci 129(2): 96-104. doi: 10.1037/bne0000048
87. Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M (2013) Modeling fall propensity in parkinson’s disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. J Neurosci 33(42): 16522-16539. doi: 10.1523/jneurosci.2545-13.2013
88. Kucinski AJ, Koshy Cherian A, Valuskova P, Yegla B, Parikh V, Robinson T, Sarter M (2015) Prone to addiction as well as to falls: poor attention in sign-tracking rats extends to complex movement control and is associated with regression of choline transporter capacity. Society for Neuroscience Annual Meeting, Chicago, IL
89. Lambe EK, Picciotto MR, Aghajanian GK (2003) Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28(2): 216-225. doi: 10.1038/sj.npp.1300032
90. Laycock R, Crewther SG, Crewther DP (2007) A role for the ‘magnocellular advantage’ in visual impairments in neuro developmental and psychiatric disorders. Neurosci Biobehav Rev 31 (3): 363-376. doi: 10.1016/j.neubiorev.2006.10.003
91. Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ (2014) Enhanced distraction by magnocellular salience signals in schizophrenia. Neuropsychologia 56: 359-366. doi: 10.1016/j.neuropsychologia.2014.02.011
92. Lesh TA, Niendam TA, Minzenberg MJ, Carter CS (2011) Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology 36(1): 316-338. doi: 10.1038/npp.2010.156
93. Luck SJ, Gold JM (2008) The construct of attention in schizophrenia. Biol Psychiatry 64 (1): 34-39. doi: 10.1016/j.biopsych.2008.02.014
94. Luck SJ, Ford JM, Sarter M, Lustig C (2012) CNTRICS final biomarker selection: control of attention. Schizophr Bull 38(1): 53-61. doi: 10.1093/schbul/sbr065
95. Lukatch HS, MacIver MB (1997) Physiology, pharmacology, and topography of cholinergic neocortical oscillations in vitro. J Neurophysiol 77(5): 2427-2445
96. Lustig C, Jantz T (2015) Questions of age differences in interference control: When and how, not if? Brain Res 1612: 59-69
97. Lustig C, Kozak R, Sarter M, Young JW, Robbins TW (2013) CNTRICS final animal model task selection: control of attention. Neurosci Biobehav Rev 37(9): 2099-2110. doi: 10.1016/j.neubiorev.2012.05.009
98. MacDonald SWS, Nyberg L, Backman L (2006) Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity. Trends Neurosci 29(8): 474-480. doi: 10.1016/j.tins.2006.06.011
99. Manoach DS (2003) Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 60(2-3): 285-298. doi: 10.1016/s0920-9964(02)00294-3
100. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45(9): 1128-1137. doi: 10.1016/s0006-3223(98)00318-7
101. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48(2): 99-109. doi: 10.1016/s0006-3223(00)00227-4
102. Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34 (1): 74-89. doi: 10.1038/npp.2008.173
103. Markou A, Salamone JD, Bussey TJ, Mar AC, Brunnerd D, Gilmour G, Balsam P (2013) Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev 37(9): 2149-2165. doi: 10.1016/j.neubiorev.2013.08.007
104. Martinez V, Sarter M (2004) Lateralized attentional functions of cortical cholinergic inputs. Behav Neurosci 118(5): 984-991. doi: 10.1037/0735-7044.118.5.984
105. Mattay VS, Fera F, Tessitore A, Hariri AR, Berman KF, Das S, Weinberger DR (2006) Neurophysiological correlates of age-related changes in working memory capacity. Neurosci Lett 392(1-2): 32-37. doi: 10.1016/j.neulet.2005.09.025
106. Matthysse S, Levy DL, Wu YN, Rubin DB, Holzman P (1999) Intermittent degradation in performance in schizophrenia. Schizophr Res 40(2): 131-146. doi: 10.1016/s0920-9964(99)00038-9
107. McGaughy J, Sarter M (1995) Behavioral vigilance in rats-task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117(3): 340-357. doi: 10.1007/bf02246109
108. McGaughy J, Sarter M (1999) Effects of ovariectomy, 192 IgG-saporin-induced cortical cholinergic deafferentatino, and administration of estradiol on sustained attention performance in rats. Behav Neurosci 113: 1216-1232
109. Mechawar N, Cozzari C, Descarries L (2000) Cholinergic innervation in adult rat cerebral cortex: a quantitative immunocytochemical description. J Comp Neurol 428: 305-318
110. Meltzer HY (2015) Pharmacotherapy of cognition in schizophrenia. Curr Opin Behav Sci 4: 115-121
111. Mendelsohn A, Pine A, Schiller D (2014) Between thoughts and actions: motivationally salient cues invigorate mental action in the human brain. Neuron 207-217. DOI: 10.1016/j.neuron.2013.10.019
112. Meyer PJ, Lovic V, Saunders BT, Yager LM, Flagel SB, Morrow JD, Robinson TE (2012) Quantifying individual variation in the propensity to attribute incentive salience to reward cues. Plos One 7(6). doi: 10.1371/journal.pone.0038987
113. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC (2009) Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 66(8): 811-822
114. Money TT, Scarr E, Udawela M, Gibbons AS, Jeon WJ, Seo MS, Dean B (2010) Treating schizophrenia: novel targets for the cholinergic system. Cns Neurol Disord Drug Targets 9 (2): 241-256
115. Muñoz W, Rudy B (2014) Spatiotemporal specificity in cholinergic control of neocortical function. Curr Opin Neurobiol 26C: 149-160
116. Neigh GN, Arnold HM, Rabenstein RL, Sarter M, Bruno JP (2004) Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release. Neuroscience 123: 635-645
117. Nelson CL, Sarter M, Bruno JP (2005) Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex. Neuroscience 132: 347-359
118. Newman EL, Gupta K, Climer JR, Monaghan CK, Hasselmo ME (2012) Cholinergic modulation of cognitive processing: insights drawn from computational models. Frontiers Behav Neurosci 6. doi: 10.3389/fnbeh.2012.00024
119. Nielsen MO, Rostrup E, W S, Bak N, Broberg BV, Lublin H, Glenthoj B (2012) Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry 69(12): 1195-1204. doi: 10.1001/archgenpsychiatry.2012.847
120. Nikolaus S, Hautzel H, Mueller H-W (2014) Neurochemical dysfunction in treated and nontreated schizophrenia-a retrospective analysis of in vivo imaging studies. Rev Neurosci 25(1): 25-96. doi: 10.1515/revneuro-2013-0063
121. Nuechterlein KH, Dawson ME (1984) Information-processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 10(2): 160-203
122. Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009) CNTRICS final task selection: control of attention. Schizophr Bull 35(1): 182-196. doi: 10.1093/schbul/sbn158
123. O’Connell RG, Dockree PM, Robertson IH, Bellgrove MA, Foxe JJ, Kelly SP (2009) Uncovering the neural signature of lapsing attention: electrophysiological signals predict errors up to 20s before they occur. J Neurosci 29(26): 8604-8611. doi: 10.1523/jneurosci.5967-08.2009
124. Paolone G, Angelakos CC, Meyer PJ, Robinson TE, Sarter M (2013a) Cholinergic control over attention in rats prone to attribute incentive salience to reward cues. J Neurosci 33: 8321-8335
125. Paolone G, Mallory CS, Cherian AK, Miller TR, Blakely RD, Sarter M (2013b) Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits. Neuropharmacology 75: 274-285
126. Parikh V, Kozak R, Martinez V, Sarter M (2007) Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56(1): 141-154. doi: 10.1016/j.neuron.2007.08.025
127. Parikh V, Man K, Decker MW, Sarter M (2008) Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci 28(14): 3769-3780. doi: 10.1523/jneurosci.5251-07.2008
128. Parikh V, Ji J, Decker MW, Sarter M (2010) Prefrontal beta 2 subunit-containing and alpha 7nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J Neurosci 30(9): 3518-3530. doi: 10.1523/jneurosci.5712-09.2010
129. Parikh V, Peters MS, Blakely RD, Sarter M (2013) The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. J Neurosci 33(6): 2326-2337. doi: 10.1523/jneurosci.4993-12.2013
130. Parry AMM, Scott RB, Palace J, Smith S, Matthews PM (2003) Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 126: 2750-2760. doi: 10.1093/brain/awg284
131. Peters MS, Demeter E, Lustig C, Bruno JP, Sarter M (2011) Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J Neurosci 31(26): 9760-9771. doi: 10.1523/jneurosci.1902-11.2011
132. Picciotto MR, Higley MJ, Mineur YS (2012) Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76(1): 116-129. doi: 10.1016/j.neuron.2012.08.036
133. Raizada RDS, Poldrack RA (2007) Challenge-driven attention: interacting frontal and brainstem systems. Frontiers Hum Neurosci 1: 3. doi: 10.3389/neuro.09.003.2007
134. Reinhart RMG, Zhu J, Park S, Woodman GF (2015) Synchronizing theta oscillations with direct-current stimulation strengthens adaptive control in the human brain. Proc Nat Acad Sci USA 112(30): 9448-9453. doi: 10.1073/pnas.1504196112
135. Reuter-Lorenz PA, Lustig C (2005) Brain aging: reorganizing discoveries about the aging mind. Curr Opin Neurobiol 15(2): 245-251. doi: 10.1016/j.conb.2005.03.016
136. Reuter-Lorenz PA, Cappell KA (2008) Neurocognitive aging and the compensation hypothesis. Curr Dir Psychol Sci 17(3): 177-182. doi: 10.1111/j.1467-8721.2008.00570.x
137. Riedel G, Platt B, van der Zee E (eds) (2015) Special issue of brain research: the cholinergic system and brain function. Brain Res 221
138. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163(3-4): 362-380. doi: 10.1107/s00213-002-1154-7
139. Robinson L, Platt B, Riedel G (2011) Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res 221(2): 443-465. doi: 10.1016/j.bbr.2011.01.055
140. Roche MW, Silverstein SW, Lenzenweger MF (2015) Intermittent degradation and schizotypy. Schizophr Res Cogn 2: 100-104
141. Roschke J, Wagner P, Mann K, Fell J, Grozinger M, Frank C (1996) Single trial analysis of event related potentials: a comparison between schizophrenics and depressives. Biol Psychiatry 40 (9): 844-852. doi: 10.1016/0006-3223(95)00652-4
142. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, Adams CE (2010) Research review: cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry 51(5): 535-549. doi: 10.1111/j.1469-7610.2009.02187.x
143. Roth A, Roesch-Ely D, Bender S, Weisbrod M, Kaiser S (2007) Increased event-related potential latency and amplitude variability in schizophrenia detected through wavelet-based single trial analysis. Int J Psychophysiol 66(3): 244-254. doi: 10.1016/j.ijpsycho.2007.08.005
144. Rowe AR, Mercer L, Casetti V, Sendt K-V, Giaroli G, Shergill SS, Tracy DK (2015) Dementia praecox redux: a systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia. J Psychopharmacol 29(2): 197-211. doi: 10.1177/0269881114564096
145. Sahakian BJ, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatr 154(6): 797-800. doi: 10.1192/bjp.154.6.797
146. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (tha) in alzheimers-disease-assessment of attentional and mnemonic function using cantab. Psychopharmacology 110 (4): 395-401. doi: 10.1007/bf02244644
147. Sarter M (2015) Behavioral-cognitive targets for cholinergic enhancement. Curr Opin Behav Sci 4: 22-26
148. Sarter M, Tricklebank M (2012) Revitalizing psychiatric drug discovery. Nat Rev Drug Discov 11 (6): 423-424. doi: 10.1038/nrd3755
149. Sarter M, Nelson CL, Bruno JP (2005) Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr Bull 31(1): 117-138. doi: 10.1093/schbul/sbi006
150. Sarter M, Gehring WJ, Kozak R (2006) More attention must be paid: the neurobiology of attentional effort. Brain Res Rev 51(2): 145-160. doi: 10.1016/j.brainresrev.2005.11.002
151. Sarter M, Martinez V, Kozak R (2009a) A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology 202(1-3): 237-258. doi: 10.1007/s00213-008-1216-6
152. Sarter M, Parikh V, Howe WM (2009b) PERSPECTIVES phasic acetylcholine release and the volume transmission hypothesis: time to move on. Nat Rev Neurosci 10(5): 383-386. doi: 10.1038/nrn2635
153. Sarter M, Lustig C, Taylor SF (2012) Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology 62(3): 1544-1553. doi: 10.1016/j.neuropharm.2010.12.001
154. Sarter M, Lustig C, Howe WM, Gritton H, Berry AS (2014) Deterministic functions of cortical acetylcholine. Eur J Neurosci 39(11): 1912-1920. doi: 10.1111/ejn.12515
155. Sarter M, Howe WM, Gritton H (2015) Cortical cholinergic transients for cue detection and attentional mode shifts. In: Wilson GS, Michael AC (eds) Compendium of in vivo monitoring in real-time molecular neuroscience. World Scientific, Singapore, pp 27-44
156. Saunders BT, Robinson TE (2012) The role of dopamine in the accumbens core in the expression of Pavlovian-conditioned responses. Eur J Neurosci 36(4): 2521-2532. doi: 10.1111/j.1460-9568.2012.08217.x
157. Scarr E, Cowie TF, Kanellakis S, Sundram S, Pantelis C, Dean B (2009) Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Mol Psychiatr 14 (11): 1017-1023. doi: 10.1038/mp.2008.28
158. Schneider-Garces NJ, Gordon BA, Brumback-Peltz CR, Shin E, Lee Y, Sutton BP, Fabiani M (2010) Span, CRUNCH, and beyond: working memory capacity and the aging brain. J Cogn Neurosci 22(4): 655-669. doi: 10.1162/jocn.2009.21230
159. Scognamiglio C, Houenou J (2014) A meta-analysis of fMRI studies in healthy relatives of patients with schizophrenia. Aust N Z J Psychiatr 48(10): 907-916. doi: 10.1177/0004867414540753
160. Sebastian A, Baldermann C, Feige B, Katzev M, Scheller E, Hellwig B, Kloeppel S (2013) Differential effects of age on subcomponents of response inhibition. Neurobiol Aging 34 (9): 2183-2193. doi: 10.1016/j.neurobiolaging.2013.03.013
161. Seo MS, Scarr E, Dean B (2014) An investigation of the factors that regulate muscarinic receptor expression in schizophrenia. Schizophr Res 158(1-3): 247-254. doi: 10.1016/j.schres.2014.06.039
162. Sesack SR, Grace AA (2010) Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35: 27-47
163. Shoshina II, Shelepin YE, Semenova NB (2014) Frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia treated with atypical and typical antipsychotics. Hum Physiol 40(1): 35-39. doi: 10.1134/s0362119714010150
164. Silverstein SM, Matteson S, Knight RA (1996) Reduced top-down influence in auditory perceptual organization in schizophrenia. J Abnorm Psychol 105(4): 663-667
165. Skottun BC, Skoyles JR (2007) Contrast sensitivity and magnocellular funciton in schizophrenia. Vision Res 47: 2923-2933
166. Small DM, Gitelman D, Simmons K, Bloise SM, Parrish T, Mesulam MM (2005) Monetary incentives enhance processing in brain regions mediating top-down control of attention. Cereb Cortex 15: 1855-1865
167. Smiley JF, Subramanian M, Mesulam MM (1999) Monoaminergic-cholinergic interactions in the primate basal forebrain. Neuroscience 93: 817-829
168. Theeuwes J (1992) Perceptual selectivity for color and form. Percept Psychophys 51(6): 599-606. doi: 10.3758/bf03211656
169. Thiele A (2013) Muscarinic signaling in the brain. Annu Rev Neurosci 36(36): 271-294. doi: 10.1146/annurev-neuro-062012-170433
170. Torgalsboen A-K, Mohn C, Rund BR (2014) 2 Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia. Psychiatr Res 216(1): 1-5. doi: 10.1016/j.psychres.2014.01.031
171. Torgalsboen A-K, Mohn C, Czajkowski N, Rund BR (2015) Relationship between neurocognition and functional recovery in first-episode schizophrenia: results from the second year of the Oslo multi-follow-up study. Psychiatr Res 227(2-3): 185-191. doi: 10.1016/j.psychres.2015.03.037
172. Umbriaco D, Watkins KC, Descarries L, Cozzari C, Hartman BK (1994) Ultrastructural and morphometric features of the acetylcholine innervation in adult rat parietal cortex: an electron microscopic study in serial sections. J Comp Neurol 348: 351-373
173. Van Snellenberg JX, Torres IJ, Thornton AE (2006) Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 20(5): 497-510. doi: 10.1037/0894-4105.20.5.497.supp
174. Van Snellenberg JX, Girgis RR, Read C, Thompson JL, Weber J, Wager TD, Slifstein M, Lieberman JA, Abi-Dargham A, Smith EE (2013) Individuals with schizophrenia fail to show normative inverted-U activation in response to fine-grained working memory load manipulation. Schizophr Bull 39: S251-S252 (Abstract)
175. Van Snellenberg JX, Slifstein M, Read C, Weber J, Thompson JL, Wager TD, Smith EE (2015) Dynamic shifts in brain network activation during supracapacity working memory task performance. Hum Brain Mapp 36(4): 1245-1264. doi: 10.1002/hbm.22699
176. Watanabe M, Sakagami M (2007) Integration of cognitive and motivational context information in the primate prefrontal cortex. Cereb Cortex 17: I101-I109. doi: 10.1093/cercor/bhm067
177. Weinberger DR, Harrison P (2011) Schizophrenia, 3rd edn. Wiley, New York
178. Wohlberg GW, Kornetsk C (1973) Sustained attention in remitted schizophrenics. Arch Gen Psychiatr 28(4): 533-537
179. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992) Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatr 49(12): 959-965
180. Wong EHF, Yocca F, Smith MA, Lee C-M (2010) Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters’ perspective. Int J Neuropsychopharmacol 13(9): 1269-1284. doi: 10.1017/s1461145710000866
181. Xiang Z, Huguenard JR, Prince DA (1998) Cholinergic switching within neocortical inhibitory networks. Science 281: 985-988
182. Young JW, Markou A (2015) Translational rodent paradigms to investigate neuromechanisms underlying behaviors relevant to amotivation and altered reward processing in schizophrenia. Schizophr Bull 41(5): 1024-1034. doi: 10.1093/schbul/sbv093
183. Young JW, Light GA, Marston HM, Sharp R, Geyer MA (2009) The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. Plos One 4(1). doi: 10.1371/journal.pone.0004227
184. Young JW, Zhou X, Geyer MA (2010) Animal models of schizophrenia. In: Swerdlow NR (ed) Behavioral neurobiology of schizophrenia and its treatment, vol 4, pp 391-433
185. Zaborszky L, Cullinan WE (1992) Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat. Brain Res 570: 92-101
186. Zaborszky L, Cullinan WE (1996) Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-β-hydroxylase-and tyrosine hydroxylase input to cholinergic neurons. J Comp Neurol 374: 535-554
187. Zaborszky L, Gaykema RP, Swanson DJ, Cullinan WE (1997) Cortical input to the basal forebrain. Neuroscience 79: 1051-1078
188. Zaborszky L, Buhl DL, Pobalashingham S, Bjaalie JG, Nadasdy Z (2005) Three-dimensional chemoarchitecture of the basal forebrain: spatially specific association of cholinergic and calcium binding protein-containing neurons. Neuroscience 136: 697-713
189. Zaborszky L, Hoemke L, Mohlberg H, Schleicher A, Amunts K, Zilles K (2008) Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage 42: 1127-1141
190. Zaborszky L, van den Pol A, Gyengesi E (2012) The basal forebrain cholinergic projection system in mice. In: The mouse nervous system. Elsevier, Pennsylvania, pp 684-718
191. Zaborszky L, Csordas A, Mosca K, Kim J, Gielow MR, Vadasz C, Nadasdy Z (2015a) Neurons in the basal forebrain project to the cortex in a complex topographic organization that reflects corticocortical connectivity patterns: an experimental study based on retrograde tracing and 3D reconstruction. Cereb Cortex 25: 118-137
192. Zaborszky L, Duque A, Gielow M, Gombkoto P, Nadasdy Z, Somogyi J (2015b) Organization of the basal forebrain cholinergic projection system: specific or diffuse? In: Paxinos G (ed) The Rat Nervous System. Academic Press, San Diego, pp 491-507